Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes. Rosenstock J, Hsia S, Nevarez Ruiz L, Eyde S, et al. N Engl J Med 2025 Jun 21. doi: 10.1056/NEJMoa2505669.

Read + Share

Amedeo Smart

Independent Medical Education

Rosenstock J, Hsia S, Nevarez Ruiz L, Eyde S, et al. Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes. N Engl J Med 2025 Jun 21. doi: 10.1056/NEJMoa2505669.
PMID: 40544435